Beverly M Kocarnik1, Edward J Boyko2, Alvin M Matsumoto3, Wilfred Y Fujimoto4, Tomoshige Hayashi5, Donna L Leonetti6, Stephanie T Page4. 1. General Medicine and Hospital and Specialty Medicine Services, Veterans Affairs Puget Sound Health Care System, Seattle, WA, United States; Division of Endocrinology, Metabolism and Nutrition, Department of Medicine, University of Washington, Seattle, WA, United States; Seattle Epidemiologic Research and Information Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, United States. Electronic address: bmkocarnik@gmail.com. 2. General Medicine and Hospital and Specialty Medicine Services, Veterans Affairs Puget Sound Health Care System, Seattle, WA, United States; Division of Endocrinology, Metabolism and Nutrition, Department of Medicine, University of Washington, Seattle, WA, United States; Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle, WA, United States. 3. Geriatric Research, Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, United States; Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle, WA, United States. 4. Division of Endocrinology, Metabolism and Nutrition, Department of Medicine, University of Washington, Seattle, WA, United States. 5. Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle, WA, United States; Department of Preventive Medicine and Environmental Health, Graduate School of Medicine, Osaka City University, Osaka, Japan. 6. Department of Anthropology, University of Washington, Seattle, WA, United States.
Abstract
PROBLEM: The role of plasma estradiol in the accumulation of intra-abdominal fat (IAF) in men is uncertain. Cross-sectional studies using imaging of IAF have shown either a positive or no association. In contrast, a randomised controlled trial using an aromatase inhibitor to suppress estradiol production found an association between oestrogen deficiency and short-term IAF accumulation. No longitudinal study has been conducted to examine the relationship between plasma estradiol concentration and the change in IAF area measured using direct imaging. METHODS: This is a longitudinal observational study in community-dwelling Japanese-American men (n=215, mean age 52 years, BMI 25.4kg/m2). IAF and subcutaneous fat areas were assessed using computerized tomography (CT) at baseline, 5 and 10 years. Baseline plasma estradiol concentrations were measured using liquid chromatography-tandem mass spectrometry. RESULTS: Univariate analysis found no association between baseline estradiol concentration and baseline IAF, or 5- or 10-year changes in IAF area (r=-0.05 for both time points, p=0.45 and p=0.43, respectively). Multivariate linear regression analysis of the change in IAF area by baseline estradiol concentration adjusted for age, baseline IAF area, and weight change found no association with either the 5- or 10-year IAF area change (p=0.52 and p=0.55, respectively). CONCLUSIONS: Plasma estradiol concentration was not associated with baseline IAF nor with change in IAF area over 5 or 10 years based on serial CT scans in community-dwelling Japanese-American men. These results do not support a role for oestrogen deficiency in IAF accumulation in men.
PROBLEM: The role of plasma estradiol in the accumulation of intra-abdominal fat (IAF) in men is uncertain. Cross-sectional studies using imaging of IAF have shown either a positive or no association. In contrast, a randomised controlled trial using an aromatase inhibitor to suppress estradiol production found an association between oestrogen deficiency and short-term IAF accumulation. No longitudinal study has been conducted to examine the relationship between plasma estradiol concentration and the change in IAF area measured using direct imaging. METHODS: This is a longitudinal observational study in community-dwelling Japanese-American men (n=215, mean age 52 years, BMI 25.4kg/m2). IAF and subcutaneous fat areas were assessed using computerized tomography (CT) at baseline, 5 and 10 years. Baseline plasma estradiol concentrations were measured using liquid chromatography-tandem mass spectrometry. RESULTS: Univariate analysis found no association between baseline estradiol concentration and baseline IAF, or 5- or 10-year changes in IAF area (r=-0.05 for both time points, p=0.45 and p=0.43, respectively). Multivariate linear regression analysis of the change in IAF area by baseline estradiol concentration adjusted for age, baseline IAF area, and weight change found no association with either the 5- or 10-year IAF area change (p=0.52 and p=0.55, respectively). CONCLUSIONS: Plasma estradiol concentration was not associated with baseline IAF nor with change in IAF area over 5 or 10 years based on serial CT scans in community-dwelling Japanese-American men. These results do not support a role for oestrogen deficiency in IAF accumulation in men.
Authors: Catherine A Sullivan; Steven E Kahn; Wilfred Y Fujimoto; Tomoshige Hayashi; Donna L Leonetti; Edward J Boyko Journal: Hypertension Date: 2015-05-11 Impact factor: 10.190
Authors: Kathryn A Britton; Joseph M Massaro; Joanne M Murabito; Bernard E Kreger; Udo Hoffmann; Caroline S Fox Journal: J Am Coll Cardiol Date: 2013-07-10 Impact factor: 24.094
Authors: Feng Wang; Veera Vihma; Jarkko Soronen; Ursula Turpeinen; Esa Hämäläinen; Hanna Savolainen-Peltonen; Tomi S Mikkola; Jussi Naukkarinen; Kirsi H Pietiläinen; Matti Jauhiainen; Hannele Yki-Järvinen; Matti J Tikkanen Journal: J Clin Endocrinol Metab Date: 2013-09-30 Impact factor: 5.958
Authors: Gideon Sartorius; Sasa Spasevska; Amanda Idan; Leo Turner; Elise Forbes; Anna Zamojska; Carolyn A Allan; Lam P Ly; Ann J Conway; Robert I McLachlan; David J Handelsman Journal: Clin Endocrinol (Oxf) Date: 2012-11 Impact factor: 3.478
Authors: Ian J Neeland; Colby R Ayers; Anand K Rohatgi; Aslan T Turer; Jarett D Berry; Sandeep R Das; Gloria L Vega; Amit Khera; Darren K McGuire; Scott M Grundy; James A de Lemos Journal: Obesity (Silver Spring) Date: 2013-05-19 Impact factor: 5.002
Authors: Catherine Kim; Dana Dabelea; Rita R Kalyani; Costas A Christophi; George A Bray; Xavier Pi-Sunyer; Christine H Darwin; Swaytha Yalamanchi; Elizabeth Barrett-Connor; Sherita Hill Golden; Edward J Boyko Journal: J Clin Endocrinol Metab Date: 2017-09-01 Impact factor: 5.958